CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 52  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0789
LYS 10.0745
GLU 20.0058
LEU 30.0115
ARG 40.0429
CYS 50.0332
GLN 60.0343
CYS 70.0434
ILE 80.0789
LYS 90.0537
THR 100.0275
TYR 110.0218
SER 120.0200
LYS 130.0399
PRO 140.0233
PHE 150.0106
HIS 160.0328
PRO 170.0102
LYS 180.0055
PHE 190.0080
ILE 200.0096
LYS 210.0154
GLU 220.0158
LEU 230.0174
ARG 240.0335
VAL 250.0299
ILE 260.0177
GLU 270.0169
SER 280.0148
GLY 290.0229
PRO 300.0284
HIS 310.0155
CYS 320.0080
ALA 330.0470
ASN 340.0391
THR 350.0127
GLU 360.0185
ILE 370.0088
ILE 380.0116
VAL 390.0104
LYS 400.0134
LEU 410.0131
SER 420.0085
ASP 430.0181
GLY 440.0130
ARG 450.0247
GLU 460.0196
LEU 470.0229
CYS 480.0250
LEU 490.0128
ASP 500.0095
PRO 510.0196
LYS 520.0168
GLU 530.0082
ASN 540.0114
TRP 550.0086
VAL 560.0049
GLN 570.0050
ARG 580.0059
VAL 590.0057
VAL 600.0095
GLU 610.0118
LYS 620.0166
PHE 630.0100
LEU 640.0125
LYS 650.0109
ARG 660.0043
ALA 670.0095
GLU 680.0244
ASN 690.0269

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.